UPDATED Apr 23, 2024
Discover large cap French Pharmaceuticals & Biotech companies that are on the CAC. These Pharmaceuticals & Biotech Companies are organised by Market Cap.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
SAN | €88.85 | 2.4% | -15.1% | €110.9b | €107.76 | PE20.5x | E13.6% | 4.2% | ||
DIM | €208.70 | -17.3% | -13.5% | €20.3b | €252.92 | PE79.7x | E23.3% | 0.3% | ||
ERF | €61.60 | 4.2% | 1.9% | €11.9b | €60.00 | PE46.3x | E19.7% | 0.8% | ||
IPN | €111.40 | 3.5% | 3.1% | €9.2b | €124.63 | PE14.9x | E6.0% | 1.1% | ||
VIRP | €359.00 | -0.3% | 17.5% | €3.0b | €361.56 | PE24.8x | E11.2% | 0.4% | ||
VETO | €98.90 | 2.4% | 15.3% | €1.2b | €108.42 | PE21x | E5.0% | 0.9% | ||
ABVX | €15.18 | 8.4% | -0.5% | €955.1m | €35.74 | PS212.6x | E14.6% | n/a | ||
BOI | €34.05 | 0.3% | -12.1% | €591.2m | €39.60 | PE12.4x | E-0.3% | 3.2% | ||
VLA | €3.72 | -0.1% | -19.2% | €516.3m | €8.95 | PS3.4x | E50.9% | n/a | ||
MEDCL | €12.28 | 31.9% | 36.7% | €353.0m | €16.75 | PS25x | E68.2% | n/a | ||
NANO | €5.75 | 6.5% | 140.1% | €270.9m | €11.30 | PS40.2x | E9.5% | n/a | ||
EAPI | €2.76 | 1.5% | -74.4% | €261.9m | €4.72 | PB0.3x | E85.2% | n/a | ||
ALSEN | €0.72 | 1.1% | 128.1% | €198.9m | €2.38 | PS35.7x | E42.8% | n/a | ||
IPH | €2.26 | 2.7% | -13.9% | €182.7m | €6.27 | PS3x | E33.0% | n/a | ||
ALCLS | €2.42 | 2.5% | 35.8% | €173.6m | n/a | PS7.6x | E45.9% | n/a | ||
AELIS | €13.00 | 0.8% | -7.8% | €170.7m | €20.67 | PS13.8x | E-43.4% | n/a | ||
IVA | €3.12 | -0.2% | 42.8% | €162.3m | €13.83 | PS7x | E17.6% | n/a | ||
GNFT | €3.24 | 1.6% | -4.0% | €160.8m | €9.38 | PS4.7x | E54.7% | n/a | ||
ALERS | €14.42 | -2.6% | -12.6% | €147.4m | €30.00 | PE30.7x | E36.3% | n/a | ||
TNG | €1.32 | -8.8% | -29.0% | €132.9m | €3.50 | PS16.8x | E-26.1% | n/a | ||
OSE | €5.97 | 28.4% | 41.8% | €128.8m | €7.15 | PS57.8x | E92.9% | n/a | ||
ADOC | €8.62 | -0.6% | 202.5% | €123.2m | €9.70 | PS11.4x | E84.1% | n/a | ||
DBV | €1.21 | -5.6% | -58.7% | €116.2m | €4.78 | PS7.9x | E53.3% | n/a | ||
PCA | €8.00 | 0% | 11.1% | €109.9m | n/a | PE12.5x | n/a | 0% |